Document 0978 DOCN M9650978 TI Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS). DT 9505 AU Akarid K; Pocidalo MA; Desforges B; Sinet M; INSERM U 13, Hopital Bichat-Claude Bernard, Paris, France. SO Eur Cytokine Netw. 1995 May-Jun;6(3):181-5. Unique Identifier : AIDSLINE MED/96159499 AB The role of T helper 1 (Th1) and T helper 2 (Th2) responses in the murine acquired immunodeficiency syndrome (MAIDS) is unclear. It has been suggested that differential activation of T cell subsets, particularly a shift to Th2 cytokine production, may be associated with disease progression. To clarify the regulation of the cytokine network in the course of MAIDS, we examined the kinetics of cytokine production by isolated splenocytes. C57/BL6 mice were infected with the LP-BM5 mixture. The spleen cell proliferative response, together with IL-2, IFN-gamma, IL-10 and IL-4 production by unstimulated and ConA or anti-CD3 MoAb-stimulated spleen cells, were determined at various times after inoculation (weeks 1, 3, 6 and 9). Spleen cells isolated from murine leukemia virus complex (LP-BM5) infected mice spontaneously produced significant amounts of IL-2 and IFN-gamma one and three weeks post-infection, compared to uninfected controls. The capacity of isolated T cells to produce the Th1 cytokines IL-2 and IFN-gamma in response to stimulation with ConA and anti-CD3 MoAb decreased after 3 weeks of infection. The fall in IL-2 production ran parallel to the fall in the T cell proliferative response to ConA. IL-10 production in response to ConA and anti-CD3 MoAb increased after three weeks post-inoculation, and followed the reverse kinetic pattern to IFN-gamma and IL-2. In contrast, no significant spontaneous IL-4 production and no increase in IL-4 production in response to ConA or anti-CD3 MoAb occurred during the course of MAIDS, relative to uninfected controls. These results suggest that LP-BM5 infection leads to a fall in Th1 cytokine production rather than a clear switch to Th2 cytokine production. DE Animal Cells, Cultured Concanavalin A/PHARMACOLOGY Cytokines/*BIOSYNTHESIS/GENETICS Female Gene Expression Regulation/DRUG EFFECTS Interferon Type II/BIOSYNTHESIS/GENETICS Interleukin-10/BIOSYNTHESIS/GENETICS Interleukin-2/BIOSYNTHESIS/GENETICS Interleukin-4/BIOSYNTHESIS/GENETICS Kinetics Lymphocyte Transformation Mice Mice, Inbred C57BL Mitogens/PHARMACOLOGY Murine Acquired Immunodeficiency Syndrome/*PATHOLOGY Muromonab-CD3/PHARMACOLOGY Spleen/*METABOLISM/PATHOLOGY Th1 Cells/*METABOLISM Th2 Cells/*METABOLISM JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).